Literature DB >> 30827828

Can a patient-tailored treatment approach for Graves' disease reduce mortality?

Luigi Bartalena1, Eliana Piantanida2, Maria Laura Tanda2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30827828     DOI: 10.1016/S2213-8587(19)30057-9

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  2 in total

1.  Should radioiodine now be first line treatment for Graves' disease?

Authors:  Onyebuchi E Okosieme; Peter N Taylor; Colin M Dayan
Journal:  Thyroid Res       Date:  2020-03-09

Review 2.  Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher.

Authors:  Daniela Gallo; Eliana Piantanida; Matteo Gallazzi; Luigi Bartalena; Maria Laura Tanda; Antonino Bruno; Lorenzo Mortara
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-17       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.